- Compression Stockings
- Gradual or medical compression stockings
- Anti-embolism stockings
- Nonmedical support hosiery
- Intermitted pneumatic compression devices
- Inferior vena cava filters
- Retrievable IVC filters
- Permanent IVC Filters
Venous Thromboembolism Devices Market Size was valued at USD 956 million in 2022 and is poised to grow at a CAGR of 8.6% from 2023-29. The global market provides a detailed overview and can be segmented by type of device, disease type, end user, and region. By type of device, the venous thromboembolism devices market has been segmented into compression stockings, gradual or medical compression stockings, anti-embolism stockings, nonmedical support hosiery, intermitted pneumatic compression devices, inferior vena cava filters, retrievable IVC filters, permanent IVC filters. By disease type, the venous thromboembolism devices market has been segmented into deep vein thrombosis and pulmonary embolism. By disease type, the pulmonary embolism segment held the largest revenue share of the venous thromboembolism devices market in past years and is expected to have the fastest growth rate over the forecasted period due to its increasing diseases rate globally. Based on the end user, the segment has been segregated into hospitals, diagnostic centers, and ambulatory surgical centers. The hospital segment is expected to lead the end-user segments owing to the increasing patient population which in turn increases the hospitalization rate worldwide.
Venous Thromboembolism Devices Market Key Development:
- In June 2021, Janssen Pharmaceuticals, Inc, a Belgium-based pharmaceutical company, announced receiving Food and Drug Administration (FDA) approval for its new product XARELTO® (rivaroxaban) for the treatment of two indications - deep venous thrombosis and pulmonary embolism. This will assist the company to strengthen its footprint in the market.
Global Venous Thromboembolism Devices Market Summary
Study Period
2023-29
Base Year
2022
CAGR
8.6%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Venous Thromboembolism Devices Market Dynamics
Increasing prevalence of pulmonary embolism disease is one of the leading factors driving the growth in the market. For instance, according to the Centers for Disease Control and Prevention, about 900,000 people in the U.S. are affected by pulmonary embolism, causing around 60,000 to 100,000 deaths every year. As several patients are at high risk of developing more serious venous thromboembolism, therapeutics such as retrievable vena cava filters are increasingly being used to stop the progression of malignant pulmonary embolism. This is further expected to enhance the sales of venous thromboembolism treatments in the market.
North America Got Significant Share Of
Venous Thromboembolism Devices Market Regional Analysis
By region, the North America market is expected to witness the highest market share during the forecast period owing to favorable reimbursement policies favoring the demand for thromboembolic therapy in the U.S. Additionally, the region also offers high incentives to doctors and physicians to use filters for prophylactic treatments. These factors are expected to accelerate the sales of venous thromboembolism treatments in the U.S.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The venous thromboembolism devices market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Venous Thromboembolism Devices Market Segmentation
By Type Of Device
By Disease Type
- Deep vein thrombosis
- Pulmonary embolism
By End User
- Hospitals
- Diagnostic centres
- Ambulatory surgical centres
Frequently Asked Questions
The venous thromboembolism devices market is projected to expand at a CAGR of 8.6% during the forecast period
Fukuda Denshi Co., Ltd (Japan), Baxter International Inc, Lidco Group Plc, All Pro Corporation, Abbott Laboratories
North America is the fastest-growing region for venous thromboembolism devices market
In terms of indication, the deep venous thrombosis segment is expected to account for a significant share of the total venous thromboembolism treatment sales market in 2022.
| 1.Executive Summary |
| 2.Global Venous Thromboembolism Devices Market Introduction |
| 2.1.Global Venous Thromboembolism Devices Market - Taxonomy |
| 2.2.Global Venous Thromboembolism Devices Market - Definitions |
| 2.2.1.Type Of Device |
| 2.2.2.Disease Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Venous Thromboembolism Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Venous Thromboembolism Devices Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Venous Thromboembolism Devices Market By Type Of Device, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Compression Stockings |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Gradual or medical compression stockings |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Anti-embolism stockings |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Nonmedical support hosiery |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Intermitted pneumatic compression devices |
| 5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Inferior vena cava filters |
| 5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Retrievable IVC filters |
| 5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Permanent IVC Filters |
| 5.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6.Global Venous Thromboembolism Devices Market By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Deep vein thrombosis |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Pulmonary embolism |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Venous Thromboembolism Devices Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic centres |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory surgical centres |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Venous Thromboembolism Devices Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Venous Thromboembolism Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Type Of Device Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Compression Stockings |
| 9.1.2.Gradual or medical compression stockings |
| 9.1.3.Anti-embolism stockings |
| 9.1.4.Nonmedical support hosiery |
| 9.1.5.Intermitted pneumatic compression devices |
| 9.1.6.Inferior vena cava filters |
| 9.1.7.Retrievable IVC filters |
| 9.1.8.Permanent IVC Filters |
| 9.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Deep vein thrombosis |
| 9.2.2.Pulmonary embolism |
| 9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Diagnostic centres |
| 9.3.3.Ambulatory surgical centres |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Venous Thromboembolism Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Type Of Device Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Compression Stockings |
| 10.1.2.Gradual or medical compression stockings |
| 10.1.3.Anti-embolism stockings |
| 10.1.4.Nonmedical support hosiery |
| 10.1.5.Intermitted pneumatic compression devices |
| 10.1.6.Inferior vena cava filters |
| 10.1.7.Retrievable IVC filters |
| 10.1.8.Permanent IVC Filters |
| 10.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Deep vein thrombosis |
| 10.2.2.Pulmonary embolism |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Diagnostic centres |
| 10.3.3.Ambulatory surgical centres |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Venous Thromboembolism Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Type Of Device Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Compression Stockings |
| 11.1.2.Gradual or medical compression stockings |
| 11.1.3.Anti-embolism stockings |
| 11.1.4.Nonmedical support hosiery |
| 11.1.5.Intermitted pneumatic compression devices |
| 11.1.6.Inferior vena cava filters |
| 11.1.7.Retrievable IVC filters |
| 11.1.8.Permanent IVC Filters |
| 11.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Deep vein thrombosis |
| 11.2.2.Pulmonary embolism |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Diagnostic centres |
| 11.3.3.Ambulatory surgical centres |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Venous Thromboembolism Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Type Of Device Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Compression Stockings |
| 12.1.2.Gradual or medical compression stockings |
| 12.1.3.Anti-embolism stockings |
| 12.1.4.Nonmedical support hosiery |
| 12.1.5.Intermitted pneumatic compression devices |
| 12.1.6.Inferior vena cava filters |
| 12.1.7.Retrievable IVC filters |
| 12.1.8.Permanent IVC Filters |
| 12.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Deep vein thrombosis |
| 12.2.2.Pulmonary embolism |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Diagnostic centres |
| 12.3.3.Ambulatory surgical centres |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Venous Thromboembolism Devices Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Type Of Device Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Compression Stockings |
| 13.1.2.Gradual or medical compression stockings |
| 13.1.3.Anti-embolism stockings |
| 13.1.4.Nonmedical support hosiery |
| 13.1.5.Intermitted pneumatic compression devices |
| 13.1.6.Inferior vena cava filters |
| 13.1.7.Retrievable IVC filters |
| 13.1.8.Permanent IVC Filters |
| 13.2. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Deep vein thrombosis |
| 13.2.2.Pulmonary embolism |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Diagnostic centres |
| 13.3.3.Ambulatory surgical centres |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Fukuda Denshi Co., Ltd (Japan) |
| 14.2.2.Baxter International Inc. (U.S) |
| 14.2.3.Lidco Group Plc. (U.K) |
| 14.2.4.All Pro Corporation (China) |
| 14.2.5.Abbott Laboratories (U.S) |
| 14.2.6.Accellent, Inc.(U.S) |
| 14.2.7.Cardiva Medical, Inc.(U.S) |
| 14.2.8.Biosensors International Group, Ltd.(Singapore) |
| 14.2.9.3M Healthcare (U.S) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Fukuda Denshi Co., Ltd (Japan)
- Baxter International Inc. (U.S)
- Lidco Group Plc. (U.K)
- All Pro Corporation (China)
- Abbott Laboratories (U.S)
- Accellent, Inc.(U.S)
- Cardiva Medical, Inc.(U.S)
- Biosensors International Group, Ltd.(Singapore)
- 3M Healthcare (U.S)